SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer

Summary

This randomized phase II trial is studying how well SB-715992 works in treating patients with advanced or metastatic colorectal cancer. Drugs used in chemotherapy, such as SB-715992, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Timeline

Start

2005-01

Primary completion

2010-01

Completion

2010-09

Drugs

Indications